New shot aims to lower bad cholesterol in early trial
Disease control
Recruiting now
This early-phase study tests a new injectable drug, COR-1004, for safety and proper dosing in people with high LDL (bad) cholesterol. About 60 healthy volunteers who are not on cholesterol meds will receive a single shot of the drug or a placebo. Researchers will monitor side eff…
Phase: PHASE1 • Sponsor: Corsera Health • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC